Straumann (OTCMKTS:SAUHY)‘s stock had its “neutral” rating reaffirmed by investment analysts at UBS Group in a note issued to investors on Monday, The Fly reports.
SAUHY has been the subject of a number of other research reports. Stifel Nicolaus downgraded shares of Straumann from a “buy” rating to a “hold” rating in a research note on Monday, January 11th. Berenberg Bank reissued a “hold” rating on shares of Straumann in a research note on Tuesday, April 13th. Deutsche Bank Aktiengesellschaft raised shares of Straumann from a “hold” rating to a “buy” rating in a research note on Monday, February 8th. JPMorgan Chase & Co. raised Straumann from a “neutral” rating to an “overweight” rating in a research report on Friday, April 30th. Finally, Credit Suisse Group reaffirmed an “outperform” rating on shares of Straumann in a research report on Friday, April 30th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the company. The company presently has a consensus rating of “Hold”.
Shares of OTCMKTS SAUHY opened at $73.94 on Monday. The stock has a 50 day moving average price of $65.70 and a 200 day moving average price of $60.38. Straumann has a 52-week low of $33.49 and a 52-week high of $73.94.
Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Europe, Sales Distributor & Emerging Markets EMEA, Sales NAM, Sales APAC, Sales LATAM, and Operations.
See Also: Tariff
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.